SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054519
Filing Date
2021-11-04
Accepted
2021-11-04 16:32:47
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eigr-10q_20210930.htm   iXBRL 10-Q 2829496
2 EX-10.1 eigr-ex101_46.htm EX-10.1 58127
3 EX-10.2 eigr-ex102_65.htm EX-10.2 116569
4 EX-31.1 eigr-ex311_9.htm EX-31.1 16844
5 EX-31.2 eigr-ex312_7.htm EX-31.2 16908
6 EX-32.1 eigr-ex321_8.htm EX-32.1 5748
  Complete submission text file 0001564590-21-054519.txt   9366935

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eigr-20210930.xsd EX-101.SCH 57907
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20210930_cal.xml EX-101.CAL 54989
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20210930_def.xml EX-101.DEF 158729
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20210930_lab.xml EX-101.LAB 434220
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20210930_pre.xml EX-101.PRE 319166
12 EXTRACTED XBRL INSTANCE DOCUMENT eigr-10q_20210930_htm.xml XML 1733223
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 211380491
SIC: 2836 Biological Products, (No Diagnostic Substances)